Cargando…

Improving detection of familial hypercholesterolaemia in primary care using electronic audit and nurse‐led clinics

RATIONALE, AIMS AND OBJECTIVES: In the UK fewer than 15% of familial hypercholesterolemia (FH) cases are diagnosed, representing a major gap in coronary heart disease prevention. We wished to support primary care doctors within the Medway Clinical Commissioning Group (CCG) to implement NICE guidance...

Descripción completa

Detalles Bibliográficos
Autores principales:	Green, Peter, Neely, Dermot, Humphries, Steve E., Saunders, Tanya, Gray, Val, Gordon, Louise, Payne, Jules, Carter, Slade, Neuwirth, Clare, Rees, Alan, Gallagher, Hazel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2015
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4840360/ https://www.ncbi.nlm.nih.gov/pubmed/26608940 http://dx.doi.org/10.1111/jep.12481

Ejemplares similares

Genetic Architecture of Familial Hypercholesterolaemia
por: Sharifi, Mahtab, et al.
Publicado: (2017)

The UK National Screening Committee’s position on child–parent screening for familial hypercholesterolaemia
por: Wald, David S, et al.
Publicado: (2021)

Cardiovascular risk stratification in familial hypercholesterolaemia
por: Sharifi, Mahtab, et al.
Publicado: (2016)

Cost-Effectiveness of Screening Algorithms for Familial Hypercholesterolaemia in Primary Care
por: Jones, Matthew, et al.
Publicado: (2022)

Cost effectiveness of cascade testing for familial hypercholesterolaemia, based on data from familial hypercholesterolaemia services in the UK
por: Kerr, Marion, et al.
Publicado: (2017)

The UK Paediatric Familial Hypercholesterolaemia Register: preliminary data
por: Ramaswami, Uma, et al.
Publicado: (2017)

Improving the cost-effectiveness equation of cascade testing for familial hypercholesterolaemia
por: Pears, Robert, et al.
Publicado: (2015)

Use of targeted exome sequencing as a diagnostic tool for Familial Hypercholesterolaemia
por: Futema, Marta, et al.
Publicado: (2012)

Case-finding and genetic testing for familial hypercholesterolaemia in primary care
por: Qureshi, Nadeem, et al.
Publicado: (2021)

The UK Paediatric Familial Hypercholesterolaemia Register: Statin-related safety and 1-year growth data
por: Humphries, Steve E., et al.
Publicado: (2018)

Functional analysis of four LDLR 5′UTR and promoter variants in patients with familial hypercholesterolaemia
por: Khamis, Amna, et al.
Publicado: (2015)

Screening for familial hypercholesterolaemia in childhood: Avon Longitudinal Study of Parents and Children (ALSPAC)
por: Futema, Marta, et al.
Publicado: (2017)

Hypercholesterolaemia in a vegan.
por: Duggan, B., et al.
Publicado: (1997)

Nutraceuticals in hypercholesterolaemia: an overview
por: Santini, Antonello, et al.
Publicado: (2016)

Comparing the performance of the novel FAMCAT algorithms and established case-finding criteria for familial hypercholesterolaemia in primary care
por: Qureshi, Nadeem, et al.
Publicado: (2021)

Normal levels of inflammatory markers in treated patients with familial hypercholesterolaemia: a cross-sectional study
por: Seed, Mary, et al.
Publicado: (2012)

The genetics and screening of familial hypercholesterolaemia
por: Henderson, Raymond, et al.
Publicado: (2016)

Tendon xanthomas in familial hypercholesterolaemia
por: Bharath, Gopinath, et al.
Publicado: (2020)

Coronary heart disease mortality in severe vs. non-severe familial hypercholesterolaemia in the Simon Broome Register
por: Humphries, Steve E., et al.
Publicado: (2019)

A mixed methods study of the awareness and management of familial hypercholesterolaemia in Irish general practice
por: Homeniuk, Robyn, et al.
Publicado: (2022)

LDL-C Concentrations and the 12-SNP LDL-C Score for Polygenic Hypercholesterolaemia in Self-Reported South Asian, Black and Caribbean Participants of the UK Biobank
por: Gratton, Jasmine, et al.
Publicado: (2022)

Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study
por: Neil, Andrew, et al.
Publicado: (2008)

Hypercholesterolaemia – practical information for non-specialists
por: Soran, Handrean, et al.
Publicado: (2017)

Serum paraoxonase activity in familial hypercholesterolaemia
por: Kotani, Kazuhiko, et al.
Publicado: (2023)

Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society
por: Cuchel, Marina, et al.
Publicado: (2014)

Comparison of the characteristics at diagnosis and treatment of children with heterozygous familial hypercholesterolaemia (FH) from eight European countries
por: Ramaswami, Uma, et al.
Publicado: (2020)

Nursing Student-Led Health Education for Sixth Graders on Chicago’s South Side
por: Singer, Randi, et al.
Publicado: (2021)

Improving detection and management of familial hypercholesterolaemia in Australian general practice
por: Brett, Tom, et al.
Publicado: (2021)

Whole exome sequencing of familial hypercholesterolaemia patients negative for LDLR/APOB/PCSK9 mutations
por: Futema, Marta, et al.
Publicado: (2014)

Hypercholesterolaemia: optimal treatment by next-generation drugs?
por: van der Wall, E.E.
Publicado: (2015)

Familial hypercholesterolaemia: cholesterol efflux and coronary disease
por: Versmissen, Jorie, et al.
Publicado: (2016)

Management of homozygous familial hypercholesterolaemia in two brothers
por: Real, José, et al.
Publicado: (2018)

Familial Hypercholesterolaemia as a Predisposing Factor for Atherosclerosis
por: Poznyak, Anastasia V., et al.
Publicado: (2022)

Dietary intervention for children and adolescents with familial hypercholesterolaemia
por: Capra, Maria Elena, et al.
Publicado: (2023)

Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment
por: Wiegman, Albert, et al.
Publicado: (2015)

Results From an All Wales Trainee Led Collaborative Prospective Audit on Management of Ankle Fractures
por: Gokhale, Sandeep, et al.
Publicado: (2021)

Coronary heart disease mortality in treated familial hypercholesterolaemia: Update of the UK Simon Broome FH register
por: Humphries, S.E., et al.
Publicado: (2018)

Controversial role of plant sterol esters in the management of hypercholesterolaemia
por: Weingärtner, Oliver, et al.
Publicado: (2009)

A perspective for sequencing familial hypercholesterolaemia in African Americans
por: Wright, Michelle L, et al.
Publicado: (2016)

Simvastatin reduces circulating oxysterol levels in men with hypercholesterolaemia
por: Dias, Irundika H.K., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_eu91hr6e6a07ngmabc8koohhgi